United States · FDA National Drug Code directory
Midol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67751-145_4efb2a06-f0fb-b6d2-e063-6294a90a92d4
- Product NDC
- 67751-145
- Form
- TABLET
- Composition / generic term
- ACETAMINOPHEN, CAFFEINE, and PYRILAMINE MALEATE
- Labeler
- Navajo Manufacturing Company Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20160919
- Source listing expiry
- 20271231
Source-listed ingredients
- ACETAMINOPHEN — 500 mg/1
- CAFFEINE — 60 mg/1
- PYRILAMINE MALEATE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 POUCH in 1 CARTON (67751-145-01) / 2 TABLET in 1 POUCH · 67751-145-01
- 2 POUCH in 1 CARTON (67751-145-02) / 4 TABLET in 1 POUCH · 67751-145-02
- 3 POUCH in 1 CARTON (67751-145-06) / 2 TABLET in 1 POUCH · 67751-145-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →